Skip to main content
Home » News » Cutting Edge Glaucoma Technology

Cutting Edge Glaucoma Technology

clipart 046

Some 2.5 million North Americans struggle with glaucoma, a progressive eye disease that robs its sufferers of their vision, if unmanaged. Associated with high eye pressure and damage to the optic nerve, the main method of preventing blindness and low vision from glaucoma is by maintaining low levels of IOP (intraocular pressure). Unstable glaucoma may require frequent visits to an eye doctor for glaucoma monitoring to keep it under control.

In recent years a parallel disorder, high blood pressure, has become widely known for producing results that vary significantly, even from hour to hour. Both blood pressure and eye pressure can be affected by such a wide range of environmental and other factors – from the way you stand to the weather – that taking a single reading on a given day may not provide a good indication of patient health.

The need for more accurate diagnostic tools has prompted researchers at Stanford University and Bar Ilan University to collaborate in the development of a 24-hour a day IOP monitor for glaucoma patients. The device, which eye doctors hope will be available within a few years, is actually an eye implant!

It is so tiny, it’s designed to fit inside a standard intraocular lens – the kind used in cataract surgery – and, according to tests conducted by the U.S. Air Force, it will not distort vision.

The implanted glaucoma monitor is based on simple physics, using fluid levels in a tiny tube to precisely measure IOP. When available to the public, it may be paired with a custom smartphone app or wearable technology like Google glass to record eye pressure all the time, and the data can be shared with the patient’s ophthalmologist or optometrist.

Recent studies indicated that round-the-clock IOP monitoring would result in modified treatment for up to 80% of patients. Prevention of intraocular pressure spikes by measuring IOP throughout a 24 hour cycle would enable eye doctors to optimize a treatment plan. Since peripheral vision loss from optic nerve damage is not reversible, treatment is aimed at preventing vision loss from glaucoma. 

Dear Oakbrook Eyecare Family,

At Oakbrook Eyecare, it is always our top priority to provide everyone the best possible care, as well as to ensure the health and safety of our patients, employees, families and our community. We appreciate the trust you have in our practice, and please know that we take the health of your families very seriously.

We have been following the evolution of the COVID-19 outbreak, and have been taking guidance from the CDC, AMA, and IOA regarding the best practice and management of patient care in this rapidly changing situation.

Starting this week, we will limit our optical hours for glasses and contact lens pick-ups to Tuesday, March 17th, Thursday, March 19th, Tuesday, March 24th, and Thursday, March 26th from 9:30-6:00 p.m. For contact lens orders, we ask you to contact us during the stated hours and we will make every effort to have the contact lenses sent directly to your home.

Our clinic will suspend eye examinations and be limited to emergency eyecare only. For ocular emergencies only, please call Dr. Franceschini at 630-240-1103. For other eyecare related inquiries, please leave a message and we will return your phone call.

We greatly appreciate your understanding and will keep our patients updated via our website and email.

With warm regards,

Dr. Franceshini and Staff
(630) 571-0399